Patents and Regulatory Exclusivities: Issues in Pharmaceutical Innovation and Competition
Full report
What this is
The Congressional Research Service is a nonpartisan policy and legal analysis arm of the Library of Congress. CRS reports are written for members of Congress and their staff, not the public — but they’re made available openly through Congress.gov.
- HR 1249112th Congress
Leahy-Smith America Invents Act
Sep 16, 2011 · Became Public Law No: 112-29.
- HR 3497112th Congress
MODDERN Cures Act of 2011
Dec 2, 2011 · Referred to the Subcommittee on Intellectual Property, Competition and the Internet.
- HR 3116113th Congress
MODDERN Cures Act of 2013
Jan 9, 2014 · Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
- HR 3309113th Congress
Innovation Act
Dec 9, 2013 · Received in the Senate and Read twice and referred to the Committee on the Judiciary.
- HR 5750113th Congress
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2014
Dec 10, 2014 · Sponsor introductory remarks on measure. (CR H8938)
- HJRES 10114th Congress
Providing for the reappointment of David M. Rubenstein as a citizen regent of the Board of Regents of the Smithsonian Institution.
Apr 7, 2015 · Became Public Law No: 114-9.
- HR 9114th Congress
Innovation Act
Feb 25, 2016 · Committee on Small Business and Entrepreneurship. Hearings held. Hearings printed: S.Hrg. 114-603.
- HR 523897th Congress
Orphan Drug Act
Jan 4, 1983 · Became Public Law No: 97-414.